N6-methyladenosine (m 6 A) is the most abundant modification on eukaryotic mRNA, which regulates all steps of the mRNA life cycle. An increasing number of studies have shown that m 6 A methylation plays essential roles in tumor development. However, the relationship between m 6 A and the progression of cancers remains to be explored. Here, we reported that transforming growth factor-β (TGFβ1)-induced epithelial-mesenchymal transition (EMT) was inhibited in methyltransferase-like 3 (METTL3) knockdown (Mettl3 Mut/− ) cells. The expression of TGFβ1 was up-regulated, while self-stimulated expression of TGFβ1 was suppressed in Mettl3 Mut/− cells. We further revealed that m 6 A promoted TGFB1 mRNA decay, but impaired TGFB1 translation progress. Besides this, the autocrine of TGFβ1 was disrupted in Mettl3 Mut/− cells via interrupting TGFβ1 dimer formation. Lastly, we found that Snail, which was down-regulated in Mettl3 Mut/− cells, was a key factor responding to TGFβ1-induced EMT. Together, our research demonstrated that m 6 A performed multi-functional roles in TGFβ1 expression and EMT modulation, suggesting the critical roles of m 6 A in cancer progression regulation.structural supports for METTL3 [15][16][17]. Acting as the executor of m 6 A modification, METTL3 plays crucial roles in various biological processes, including tumor development [18,19]. For instance, METTL3 is necessary for the development and maintenance of mouse and human myeloid leukemia [20]. Our recent study indicated that METTL3 regulated the epithelial-mesenchymal transition (EMT) of cancer cells via Snail translation [21]. Although associations between m 6 A methylation and tumorigenesis, especially EMT process, have arisen for the last decade, the detailed mechanisms remained to be elucidated.EMT of cancer can be induced by a plethora of signaling pathways, and transforming growth factor β (TGFβ) is the prominent EMT inducer in cancer cells [22]. TGFβ, which contains three isoforms, TGFβ1, TGFβ2, and TGFβ3, is synthesized as a pro-protein monomer. During the maturation, the TGFβ dimer forms a complex with latent TGFβ binding proteins (LTBPs), called a latent complex [23,24], which is crucial for the secretion of TGFβ and the activation of TGFβ receptor (TGFR)-mediated cell signaling [25,26]. TGFβ induces the expression of many other growth factors and cytokines to initiate EMT, while also cooperating with the initial stimulus of TGFβ to stimulate self-expression, which is necessary for sustained signaling, which continually supports the long process of EMT [22,27].In this study, we investigate the potential effects of m 6 A on the TGFβ1-induced EMT of cancer cells. Our data reveal that TGFβ1-induced EMT is suppressed in METTL3 knockdown cells (Mettl3 Mut/− ). However, the expression of TGFβ1 is enhanced in Mettl3 Mut/− cells but decreased in TGFβ1-treated Mettl3 Mut/− cells. We demonstrate that m 6 A regulates the stability and translation of TGFB1 mRNA. In addition, METTL3 modulates the secretion and activation of TGFβ1. Besides this, we furth...